Table 1.
Demographic and clinical characteristics of populations
| Variable | SCS | VFHS | PREVEND | GRAPHIC | YMCA | TRANSLATE |
|---|---|---|---|---|---|---|
| Number of subjects | 764 | 2755 | 7687 | 1987 | 1151 | 126 |
| Male/Female | 439/325 | 1334/1421 | 3784/3903 | 1005/982 | 1151/0 | 71/55 |
| Age (years) | 55.2±11.8 | 39.7±15.8 | 49.5±12.8 | 39.3±14.5 | 19.1±3.6 | 61.1±10.5 |
| Body mass index (kg/m2) | 27.5±4.2 | 25.1±4.1 | 26.1±4.2 | 26.1±4.6 | 22.8±3.0 | 27.6±4.4 |
| Clinic systolic BP (mmHg) | 131.3±19.1 | 123.3±15.2 | 129.3±20.3 | 127.1±17.8 | 118.0±13.1 | 136.4±13.5 |
| Clinic diastolic BP (mmHg) | 74.9±11.0 | 75.7±10.7 | 75.6±11.2 | 79.2±11.0 | 74.2±7.9 | 83.2±8.0 |
| Hypertension (%) | 549 (71.9) | 515 (18.6) | 2647 (34.4) | 571 (28.7) | 120 (10.4) | 85 (67.5) |
| Antihypertensive treatment (%) | 451 (59.0) | 222 (8.1) | 1219 (15.9) | 134 (6.7) | 18 (1.6) | 74 (58.7) |
Data are counts and percentages or means and SD. SCS, Silesian Cardiovascular Study; VFHS, Victorian Family Heart Study; PREVEND, Prevention of Renal and Vascular End-stage Disease Study; YMCA, Young Men Cardiovascular Association Study.